<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20130121012210N9</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-06-18</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The Comparison of Different exercise therapy on improvement of Long-Standing  Groin Pain in Athletes</public_title>
      <acronym></acronym>
      <scientific_title>The Comparison of Different Intensities of Modified Holmich Protocol on Performance, Pain and Return-to-Sport in Athletes with Long-Standing Adductor Longus Related Groin Pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>36</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/55050</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants are divided into three intervention groups according simple randomization.  Randomization will performed using sealed, randomly filled envelopes describing the treatment groups. We prepare three envelopes, in each of which one of the three methods is written. Each participant will choose one of them without knowing the contents of the envelope and will be placed in the relevant group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Groin Pain.</hc_freetext>
      <i_freetext>Intervention 1: First intervention group: Low intensity Exercise. In this group  Maximum Voluntary Contraction of hip adduction is defined using the Dynamometer and adjust  low- intensity exercise by 10%  of Maximum Voluntary Contraction. This exercises will continue for 10 weeks. The duration of each session is one hour and will be performed three times a week. Intervention 2: Second intervention group: Moderate intensity Exercise. In this group  Maximum Voluntary Contraction of hip adduction is defined using the Dynamometer and adjust moderate-intensity exercise by 30-50%  of Maximum Voluntary Contraction. This exercises will continue for 10 weeks. The duration of each session is one hour and will be performed three times a week. Intervention 3: Third intervention group: High intensity Exercise. In this group  Maximum Voluntary Contraction of hip adduction is defined using the Dynamometer and adjust high-intensity contractions exercise by 70%  of Maximum Voluntary Contraction. This exercises will continue for 10 weeks. The duration of each session is one hour and will be performed three times a week.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more Data.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Rami Mazbouh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.11, Al Mahdi Street, Zahle Baalback Main Road Near the</address>
        <city>Zahle</city>
        <country1>Lebanon</country1>
        <zip>416543329</zip>
        <telephone>+961 3 958 673</telephone>
        <email>ramielmazbouh@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Azadeh Shadmehr</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Piche shemiran, Enghelab street.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148965111</zip>
        <telephone>+98 21 7752 8468</telephone>
        <email>shadmehr@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Male athletic with Right dominant leg
age 18-35 years
desire to return to the former level of sports activity
groin pain for at least 2 months
pain at palpation of the adductor tendons or the insertion on the pubic bone or both
moderate groin pain during active adduction against resistance (squeeze test)
moderate pain during adduction against resistance had to be more than two and less than six
at least two of the following criteria had to be present: a clear history of groin pain and stiffness in the morning, cough-induced or sneeze-induced groin pain, nocturnal groin pain , radiological evidence demonstrating osteitis pubis</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>inguinal hernia
fracture of the pelvis or the lower limbs
entrapment of the genitofemoral  nerve
taking any nonsteroidal anti-inflammatory drugs
participation in principled strength training of the hip adductors for more than once a week in the 6 months prior to the study
chronic urinary tract disorder</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G89.11</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Acute pain due to trauma</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First intervention group: Low intensity Exercise. In this group  Maximum Voluntary Contraction of hip adduction is defined using the Dynamometer and adjust  low- intensity exercise by 10%  of Maximum Voluntary Contraction. This exercises will continue for 10 weeks. The duration of each session is one hour and will be performed three times a week.</i_keyword>
      <i_keyword>Second intervention group: Moderate intensity Exercise. In this group  Maximum Voluntary Contraction of hip adduction is defined using the Dynamometer and adjust moderate-intensity exercise by 30-50%  of Maximum Voluntary Contraction. This exercises will continue for 10 weeks. The duration of each session is one hour and will be performed three times a week.</i_keyword>
      <i_keyword>Third intervention group: High intensity Exercise. In this group  Maximum Voluntary Contraction of hip adduction is defined using the Dynamometer and adjust high-intensity contractions exercise by 70%  of Maximum Voluntary Contraction. This exercises will continue for 10 weeks. The duration of each session is one hour and will be performed three times a week.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: before treatment, at the end of treatment (after the 10th week). Method of measurement: according to the Visual analog scale, patient pain will be assessed during resisted hip adduction.</prim_outcome>
      <prim_outcome>Hip adductors strength by dynamo-meter. Timepoint: before treatment, at the end of treatment (after the 10th week). Method of measurement: Average of three Maximal Voluntary Contraction (MVC) recorded on the Biodex Dynamometer during hip isometric adduction.</prim_outcome>
      <prim_outcome>Hip abductors strength by dynamo meter. Timepoint: before treatment, at the end of treatment (after the 10th week). Method of measurement: Average of three Maximal Voluntary Contraction (MVC) recorded on the Biodex Dynamometer during hip isometric abduction.</prim_outcome>
      <prim_outcome>Hip range of motion by goniometer. Timepoint: before treatment, at the end of treatment (after the 10th week). Method of measurement: It is the range of motion of the hip joint abduction recorded by goniometer.</prim_outcome>
      <prim_outcome>Time to return to sport. Timepoint: When the athlete fully returns to team training and competitions after treatment. Method of measurement: The time needed for the player to return to Sport in weeks and days.</prim_outcome>
      <prim_outcome>Figure  of  eight  hop test. Timepoint: before treatment, at the end of treatment (after the 10th week). Method of measurement: The athlete completes the 8-English course by jumping on one foot and the time of this work is recorded.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-10-31</approval_date>
        <contact_name>Ethics Committee of  School of Medicine ,Tehran University of Medical Sciences</contact_name>
        <contact_address>School of Medicine, Poorsina street, Keshavarz Ave. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
